日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Heterogeneity of tertiary lymphoid structures predicts the response to neoadjuvant therapy and immune microenvironment characteristics in triple-negative breast cancer.

三级淋巴结构的异质性可预测三阴性乳腺癌对新辅助治疗的反应和免疫微环境特征

Wang Qing, Yu Yushuai, Wang Chenxi, Jiang Zirong, Li Jialu, Li Xiaofen, Huang Xiewei, Song Ying, Li Zhenhui, Tang Shicong, Song Chuangui

Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancer

构建含溴结构域蛋白相关预后模型在三阴性乳腺癌中的应用

Chen, Wei; Yu, Yushuai; Wang, Chenxi; Jiang, Zirong; Huang, Xiewei; Lin, Yidan; Han, Hongjing; Wang, Qing; Zhang, Hui

The value of oral selective estrogen receptor degraders in patients with HR-positive, HER2-negative advanced breast cancer after progression on ≥ 1 line of endocrine therapy: systematic review and meta-analysis

口服选择性雌激素受体降解剂在接受过至少一线内分泌治疗后进展的HR阳性、HER2阴性晚期乳腺癌患者中的价值:系统评价和荟萃分析

Huang, Xiewei; Yu, Yushuai; Luo, Shiping; Fu, Wenfen; Zhang, Jie; Song, Chuangui

Correction: The value of oral selective estrogen receptor degraders in patients with HR-positive, HER2-negative advanced breast cancer after progression on ≥ 1 line of endocrine therapy: systematic review and meta-analysis

更正:口服选择性雌激素受体降解剂在接受过至少一线内分泌治疗后进展的HR阳性、HER2阴性晚期乳腺癌患者中的价值:系统评价和荟萃分析

Huang, Xiewei; Yu, Yushuai; Luo, Shiping; Fu, Wenfen; Zhang, Jie; Song, Chuangui

Unraveling the causal links and novel molecular classification of Crohn's disease in breast Cancer: a two-sample mendelian randomization and transcriptome analysis with prognostic modeling

揭示克罗恩病与乳腺癌的因果关系及新型分子分型:基于双样本孟德尔随机化和转录组分析的预后模型

Yu, Xin; Yu, Yushuai; Huang, Xiewei; Jiang, Zirong; Wang, Qing; Yu, Xiaoqin; Song, Chuangui